🇺🇸 FDA
Patent

US 11441184

Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs)

granted A61PA61P27/02A61P27/06

Quick answer

US patent 11441184 (Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs)) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61P, A61P27/02, A61P27/06, A61P9/10